A new clue to hair loss: A misbehaving enzyme in follicle stem cells – STAT
STAT |
A new clue to hair loss: A misbehaving enzyme in follicle stem cells
STAT The study, published in Nature Cell Biology 1, finds that the metabolism in the stem cells embedded in hair follicles is different from surrounding cells. When they tinkered with that metabolic pathway in mice, they could either halt hair growth — or … |
|
Europe’s first stem cell therapy backed by NICE
PharmaTimes Eisai’s Holoclar, the first stem–cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition. The National Institute for Health and Care Excellence has now … |
|
First FDA-approved stem cell trial for shoulder injuries reaches full enrollment
News-Medical.net The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used … |
|
First FDA-approved stem cell trial for shoulder injuries reaches full enrollment
News-Medical.net The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used … |
|
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
UroToday The standard of care for most patients with non-muscle-invasive bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Guérin (BCG), which activates the immune system to recognize and destroy malignant cells and has demonstrated … |